Bladder-sparing management for high grade noninvasive urothelial carcinoma of the prostate - Martin, Alexander C.; McElree, Ian M.; Mott, Sarah L.; Hougen, Helen Y.; Steinberg, Ryan L.; O'Donnell, Michael A.; Packiam, Vignesh T. (Urologic oncology, 2025)
Keywords: Adjuvants, Immunologic - administration & dosage; Administration, Intravesical; Aged; Antineoplastic Agents - administration & dosage; BCG; BCG Vaccine - administration & dosage; Bladder cancer; Carcinoma in Situ - mortality; Carcinoma in Situ - pathology; Carcinoma in Situ - therapy; Cystectomy; Docetaxel; Docetaxel - administration & dosage; Follow-Up Studies; Gemcitabine; Gemcitabine - administration & dosage; Humans; Kaplan-Meier Estimate; Male; Neoplasm Grading; Organ Sparing Treatments - methods; Organ Sparing Treatments - mortality; Proportional Hazards Models; Prostatic Neoplasms - mortality; Prostatic Neoplasms - pathology; Prostatic Neoplasms - therapy; Prostatic urethral; Retrospective Studies; Survival Rate; Treatment Outcome; Urinary Bladder - pathology; Urothelium - pathology; Prostatic urethral; Gemcitabine; Bladder cancer; Docetaxel; BCG